Light Mode
$5.05 ↑ +0.00 (+0.00%) Trading Up from the previous close of $5.05, $0.10 below the day’s high of $5.15
+3.49 (+223.72%) / 6M
Momentum, market sentiment, and recent alerts
ADIL reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +1238.1%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.